NOVA Medical School's Hub of Preclinical-to-Clinical Innovation (HubP2C) will be the epicentre of translational research in the Lisbon area, accelerating the development of new therapies from the preclinical phase to clinical trials. Integrating cutting-edge techniques, regulatory support, entrepreneurship training, mentoring, collaboration and strategic partnerships, HubP2C aims to be a national catalyst for innovation in health solutions.